Dr Ebrahim Mostafavi
Ebrahim Mostafavi is currently at Stanford Cardiovascular Institute, Stanford School of Medicine. His research interests revolve around the use of cardiac iPS cells to design and develop in vitro models (organoids, 3D bioprinted constructs, vascular grafts) for cardiovascular disease modeling and drug screening, as well as CRISPR/Cas gene-editing for cardiovascular diseases. Dr. Mostafavi received his PhD in Chemical Engineering (with a focus on Biomedical Engineering and Regenerative Medicine) from Northeastern University, Boston, MA. During his doctoral training, he received several prestigious awards. He has also received training at Harvard Medical School/Brigham and Women's Hospital on engineering and development of (nano)biomaterials and 3D scaffolds (hydrogels, 3D bioprinted constructs, and nanoporous scaffolds) to create biologically complex tissues and organs for tissue engineering, regenerative medicine, and translational applications.
Dr. Mostafavi currently serves as an Editorial Board Member for Nature Scientific Reports, Springer Nature Journal of Nanostructure in Chemistry, MDPI Functional Biomaterials, and a few other prestigious journals. He also serves as a verified peer-reviewer for over 25 different high-impact journals from respected publishers. His scholarly work consists of > 65 publications with an H-index of 20 (i10-index= 34) on Google Scholar Profile. Thus far, he contributed to >10 book chapters and was selected as the editor of a few books including “Advances in Cardiovascular Biomaterials” and "Emerging Nanomaterials to Combat Antimicrobial Resistance"
Updated 31 August 2021